OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 34

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Ernesto Fedele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14499-14499
Open Access | Times Cited: 32

Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment
Xinfu Zou, Guoqiang Zou, Xinyan Zou, et al.
PeerJ (2024) Vol. 12, pp. e17061-e17061
Open Access | Times Cited: 10

Role of microbiota-gut-brain axis in Alzheimer's disease and possible interventions
Rohini Pujari, Shreya Sharma, Shvetank Bhatt
Elsevier eBooks (2025), pp. 19-41
Closed Access | Times Cited: 1

The bilateral cross communication in microbiota-gut-brain axis as a promising therapeutic target for Alzheimer’s disease: a focus on neuroinflammation
Awgichew Shewasinad Yehualashet, Ermiyas Endewunet Melaku, Demissew Shenkute, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1

MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 20

White hyacinth bean polysaccharide ameliorates diabetes via microbiota-gut-brain axis in type 2 diabetes mellitus rats
Su-Mei Chen, Fan-Sen Zeng, Wang-Wei Fu, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127307-127307
Closed Access | Times Cited: 17

Oxidative Stress, Gut Microbiota, and Extracellular Vesicles: Interconnected Pathways and Therapeutic Potentials
Bo Ma, Muttiah Barathan, Min Hwei Ng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3148-3148
Open Access

Design, Synthesis and Anticholinesterase Activity of Coumarin‐1,3,5‐triazine Derivatives
Xiaoqing Zhang, Jing Wang, Jing‐Pei Zou, et al.
ChemistrySelect (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 4

Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by 18F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer’s Disease
Geon Ha Kim, Bori R. Kim, Hai‐Jeon Yoon, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1944-1944
Open Access | Times Cited: 3

Zeolite and Neurodegenerative Diseases
Stefan Panaiotov, Lyubka Tancheva, Reni Kalfin, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2614-2614
Open Access | Times Cited: 3

Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11272-11272
Open Access | Times Cited: 3

Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review
Daiane Oliveira Simão, V Vieira, Jéssica Abdo Gonçalves Tosatti, et al.
Nutrients (2023) Vol. 15, Iss. 21, pp. 4661-4661
Open Access | Times Cited: 7

Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease
Xiaoqing Zhang, Yan-Nan Xiang, Qin Tian, et al.
Fitoterapia (2024) Vol. 174, pp. 105867-105867
Closed Access | Times Cited: 2

Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance
Wei Tao, Yanren Zhang, Bingbin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2

Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Jana Hroudová, Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111069-111069
Closed Access | Times Cited: 2

Muscarinic Receptors and Alzheimer’s Disease: New Perspectives and Mechanisms
Martina Monaco, Hanna Trebesova, Massimo Grilli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6820-6835
Open Access | Times Cited: 2

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 2

Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
Shreyas Iyer, Shreya Verma, Sandhya Amol Marathe, et al.
(2024), pp. 271-301
Closed Access | Times Cited: 1

Exploring the Potential Role of Lactobacillus plantarum in the Reversal of Induced Cognitive Long-term Memory Impairment
Murugan Mukilan, Venkadasalapathi Elakkiya, Murugesan Darshini, et al.
Journal of Experimental Biology and Agricultural Sciences (2024) Vol. 12, Iss. 2, pp. 175-187
Open Access | Times Cited: 1

The Gut-Brain Axis in Alzheimer’s and Parkinson’s Diseases: The Catalytic Role of Mitochondria
Emanuel Candeias, A. Raquel Pereira-Santos, Nuno Empadinhas, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 413-429
Closed Access | Times Cited: 1

Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial
Katrine Lundby Høyer, Simon Mark Dahl Baunwall, Ditte Smed Kornum, et al.
EClinicalMedicine (2024) Vol. 79, pp. 103000-103000
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top